Antioxidant defence and oxidative stress markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy: a pilot study - PubMed (original) (raw)
Antioxidant defence and oxidative stress markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy: a pilot study
Marcin Michałek et al. BMC Vet Res. 2020.
Abstract
Background: Hypertrophic cardiomyopathy is the most common cardiovascular cause of death in cats. Although the majority of cats remain asymptomatic, some may develop signs of chronic heart failure due to diastolic failure, arterial thromboembolism (ATE) or sudden cardiac death. Therefore, it is crucial to identify individuals that are in high risk of developing cardiac complications before the onset of life-threatening signs. Oxidative stress is the imbalance between the production and neutralisation of reactive oxygen species. Uncontrolled reactive oxygen species overproduction leads to protein and lipid peroxidation and damages the DNA strands, injuring the cells and leading to their death. The aim of the study was to evaluate the oxidative state in cats with hypertrophic cardiomyopathy and healthy controls.
Results: In total, 30 cats divided into three groups were assessed: animals with clinically evident hypertrophic cardiomyopathy (HCM; n = 8), subclinical hypertrophic cardiomyopathy (SUB-HCM; n = 11) and healthy controls (n = 11). The activity of superoxide dismutase was statistically significantly lower in animals with symptomatic and asymptomatic hypertrophic cardiomyopathy (HCM 0.99 ± 0.35 U/mL; SUB-HCM 1.39 ± 0.4 U/mL) compared to healthy cats (2.07 ± 0.76 U/mL, p < 0.01). The activity of catalase was significantly lower in the SUB-HCM group (19.4 ± 4.2 nmol/min/mL) compared to the HCM (23.6 ± 5.9 nmol/min/mL) and the control (30 ± 7.5 nmol/min/mL, p < 0.01) group. The activity of glutathione peroxidase was 4196 ± 353 nmol/min/mL in the HCM group, 4331 ± 451 nmol/min/mL in the SUB-HCM group and 4037 ± 341 nmol/min/mL in the control group and did not differ significantly between groups. The total antioxidant capacity of plasma was 602 ± 65.5 copper reducing equivalents (CRE) in the HCM group, 605.9 ± 39.9 CRE in the SUB-HCM group and 629 ± 77.5 CRE in the healthy cats and did not differ significantly between the groups.
Conclusions: Activities of superoxide dismutase and catalase differed in cats with hypertrophic cardiomyopathy, however the activity of the latter was only significantly lower in asymptomatic stage of the disease. The potentially beneficial effect of antioxidative substances on the disease progression in the asymptomatic and symptomatic stage of this disease should also be examined.
Keywords: Antioxidative enzymes; Cardiology; Cats; Hypertrophic cardiomyopathy; Oxidative stress.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
- The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.
Kittleson MD, Côté E. Kittleson MD, et al. J Feline Med Surg. 2021 Nov;23(11):1028-1051. doi: 10.1177/1098612X211020162. J Feline Med Surg. 2021. PMID: 34693811 Free PMC article. - Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats.
Hertzsch S, Roos A, Wess G. Hertzsch S, et al. J Vet Intern Med. 2019 May;33(3):1242-1250. doi: 10.1111/jvim.15498. Epub 2019 Apr 16. J Vet Intern Med. 2019. PMID: 30990935 Free PMC article. - Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy.
Bédard C, Lanevschi-Pietersma A, Dunn M. Bédard C, et al. Vet Clin Pathol. 2007 Jun;36(2):167-72. doi: 10.1111/j.1939-165x.2007.tb00203.x. Vet Clin Pathol. 2007. PMID: 17523090 - Asymptomatic Hypertrophic Cardiomyopathy: Diagnosis and Therapy.
Luis Fuentes V, Wilkie LJ. Luis Fuentes V, et al. Vet Clin North Am Small Anim Pract. 2017 Sep;47(5):1041-1054. doi: 10.1016/j.cvsm.2017.05.002. Epub 2017 Jun 27. Vet Clin North Am Small Anim Pract. 2017. PMID: 28662873 Review. - Screening for hypertrophic cardiomyopathy in cats.
Häggström J, Luis Fuentes V, Wess G. Häggström J, et al. J Vet Cardiol. 2015 Dec;17 Suppl 1:S134-49. doi: 10.1016/j.jvc.2015.07.003. J Vet Cardiol. 2015. PMID: 26776573 Review.
Cited by
- Alterations in the Intestinal Microbiome and Metabolic Profile of British Shorthair Kittens Fed with Milk Replacer.
Wang C, Zhu Q, Li Y, Guo J, Li L. Wang C, et al. Animals (Basel). 2024 Aug 14;14(16):2346. doi: 10.3390/ani14162346. Animals (Basel). 2024. PMID: 39199879 Free PMC article. - Blood plasma and urinary biomarkers of oxidative stress in cats with urethral obstruction.
Quintavalla F, Basini G, Fidanzio F, Bussolati S, Sabetti MC, Crosta MC, Grolli S, Ramoni R. Quintavalla F, et al. BMC Vet Res. 2024 Apr 27;20(1):163. doi: 10.1186/s12917-024-04009-8. BMC Vet Res. 2024. PMID: 38678221 Free PMC article. - Supplementation with rice bran hydrolysates reduces oxidative stress and improves lipid profiles in adult dogs.
Suwannachot P, Thawornchinsombut S, Jongjareonrak A, Sringam P, Senaphan K. Suwannachot P, et al. J Vet Med Sci. 2023 Jul 1;85(7):727-734. doi: 10.1292/jvms.22-0513. Epub 2023 May 23. J Vet Med Sci. 2023. PMID: 37225448 Free PMC article. - Dietary Strategies for Relieving Stress in Pet Dogs and Cats.
Fan Z, Bian Z, Huang H, Liu T, Ren R, Chen X, Zhang X, Wang Y, Deng B, Zhang L. Fan Z, et al. Antioxidants (Basel). 2023 Feb 21;12(3):545. doi: 10.3390/antiox12030545. Antioxidants (Basel). 2023. PMID: 36978793 Free PMC article. Review. - Vitamin D Supplementation Could Enhance the Effectiveness of Glibenclamide in Treating Diabetes and Preventing Diabetic Nephropathy: A Biochemical, Histological and Immunohistochemical Study.
Atia T, Iqbal MZ, Fathy Ahmed H, Sakr HI, Abdelzaher MH, Morsi DF, Metawee ME. Atia T, et al. J Evid Based Integr Med. 2022 Jan-Dec;27:2515690X221116403. doi: 10.1177/2515690X221116403. J Evid Based Integr Med. 2022. PMID: 35942573 Free PMC article.
References
- Fox PR, Keene BW, Lamb K, Schober KA, Chetboul V, Luis Fuentes V, et al. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: the REVEAL study. J Vet Intern Med. 2018;32(3):930–943. doi: 10.1111/jvim.15122. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous